BCL2 and neoplasm: Moreover, Dreuw and co-authors demonstrated that fibroblasts, resulting from the differentiation of MSCs, mediated IL-6 secretion, leading to the overexpression of Bcl-2 and Bcl-xL in tumor cells and an inhibition of apoptosis following anti-cancer treatment [250,251].